17.40
前日終値:
$17.10
開ける:
$17.22
24時間の取引高:
2.61M
Relative Volume:
0.46
時価総額:
$8.64B
収益:
$4.45B
当期純損益:
$205.00M
株価収益率:
43.51
EPS:
0.4
ネットキャッシュフロー:
$372.00M
1週間 パフォーマンス:
+22.46%
1か月 パフォーマンス:
+16.71%
6か月 パフォーマンス:
+52.80%
1年 パフォーマンス:
+32.84%
Elanco Animal Health Inc Stock (ELAN) Company Profile
名前
Elanco Animal Health Inc
セクター
電話
877-352-6261
住所
2500 INNOVATION WAY, GREENFIELD
ELAN を他の銘柄と比較する
株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
---|---|---|---|---|---|---|
![]()
ELAN
Elanco Animal Health Inc
|
17.39 | 8.28B | 4.45B | 205.00M | 372.00M | 0.40 |
![]()
ZTS
Zoetis Inc
|
149.25 | 65.30B | 9.39B | 2.61B | 2.22B | 5.81 |
![]()
TAK
Takeda Pharmaceutical Co Adr
|
14.60 | 45.60B | 29.98B | 958.27M | 5.31B | 0.2964 |
![]()
HLN
Haleon Plc Adr
|
9.575 | 42.82B | 14.35B | 1.85B | 0 | 0.4023 |
![]()
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
16.50 | 18.78B | 16.54B | -1.64B | 749.00M | -1.45 |
![]()
UTHR
United Therapeutics Corp
|
299.06 | 13.64B | 2.99B | 1.21B | 1.13B | 25.06 |
Elanco Animal Health Inc Stock (ELAN) Upgrades & Downgrades
日付 | アクション | アナリスト | 評価の変更 |
---|---|---|---|
2025-07-17 | アップグレード | Leerink Partners | Market Perform → Outperform |
2025-06-26 | アップグレード | William Blair | Mkt Perform → Outperform |
2024-12-09 | 開始されました | UBS | Buy |
2024-12-02 | 開始されました | Leerink Partners | Market Perform |
2024-09-19 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
2024-01-05 | アップグレード | Stifel | Hold → Buy |
2023-12-19 | 開始されました | Jefferies | Buy |
2023-12-15 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
2023-12-07 | 開始されました | Exane BNP Paribas | Outperform |
2023-04-20 | アップグレード | Barclays | Equal Weight → Overweight |
2022-08-18 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
2022-08-16 | ダウングレード | JP Morgan | Overweight → Neutral |
2022-07-21 | ダウングレード | Goldman | Buy → Sell |
2022-07-12 | 開始されました | Piper Sandler | Neutral |
2021-11-18 | 開始されました | Morgan Stanley | Overweight |
2021-10-28 | ダウングレード | Stifel | Buy → Hold |
2021-08-05 | 再開されました | Credit Suisse | Outperform |
2021-06-15 | アップグレード | Cleveland Research | Underperform → Neutral |
2021-05-11 | アップグレード | Barclays | Underweight → Equal Weight |
2021-05-11 | アップグレード | Gabelli & Co | Hold → Buy |
2021-04-15 | 開始されました | Stifel | Buy |
2021-03-22 | ダウングレード | Gabelli & Co | Buy → Hold |
2021-02-26 | アップグレード | Credit Suisse | Neutral → Outperform |
2020-12-09 | ダウングレード | Argus | Buy → Hold |
2020-11-09 | ダウングレード | Barclays | Overweight → Underweight |
2020-08-20 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
2020-08-13 | 再開されました | Credit Suisse | Neutral |
2020-08-04 | 再開されました | Goldman | Buy |
2020-07-27 | ダウングレード | Cleveland Research | Neutral → Underperform |
2020-04-02 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
2020-01-10 | 開始されました | Raymond James | Mkt Perform |
2019-12-19 | アップグレード | BofA/Merrill | Neutral → Buy |
2019-11-07 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
2019-09-23 | 開始されました | Barclays | Overweight |
2019-08-26 | ダウングレード | BofA/Merrill | Buy → Neutral |
2019-08-15 | アップグレード | UBS | Sell → Neutral |
2019-05-23 | 開始されました | Guggenheim | Neutral |
2019-03-18 | アップグレード | BofA/Merrill | Neutral → Buy |
2019-03-13 | 再開されました | Morgan Stanley | Equal-Weight |
2019-02-12 | 開始されました | William Blair | Mkt Perform |
2019-01-23 | 開始されました | UBS | Sell |
2019-01-15 | 開始されました | Argus | Buy |
2018-10-15 | 開始されました | Morgan Stanley | Equal-Weight |
すべてを表示
Elanco Animal Health Inc (ELAN) 最新ニュース
ELAN Q2 Deep Dive: Innovation and Execution Drive Raised Full-Year Outlook - FinancialContent
Price Consolidation Hints at Upcoming Move in Elanco Animal Health IncorporatedReversal Alert Based on RSI Indicator Confirmed - metal.it
Elanco (ELAN) Jumps 19.7% to Record High on Earnings Boost - MSN
Elanco Animal Health Surges 9% on Q2 Results and Optimistic Full-Year Forecast - AInvest
Elanco Animal Health: Analyst Sentiment Analysis and 12-Month Price Targets - AInvest
Elanco Animal Health Second Quarter 2025 Earnings: Beats Expectations - Yahoo Finance
Elanco Animal Health Incorporated (NYSE:ELAN) Q2 2025 Earnings Call Transcript - Insider Monkey
Elanco Animal Health (ELAN) Gets a Buy from Bank of America Securities - The Globe and Mail
Chart based analysis of Elanco Animal Health Incorporated trendsTrend Confirmation Scanner with Entry Focus - Newser
ICYMI: Elanco Shares Jump After 2Q Beat-and-Raise Results - iHeart
Elanco Puppy Virus Treatment Expanded With USDA Approval - InkFreeNews.com
UBS Raises PT to $19 for Elanco Animal Health Amid Bullish Outlook - AInvest
A Quick Look at Today's Ratings for Elanco Animal Health(ELAN.US), With a Forecast Between $15 to $21 - 富途牛牛
An Intrinsic Calculation For Elanco Animal Health Incorporated (NYSE:ELAN) Suggests It's 36% Undervalued - Yahoo Finance
Elanco Animal Health shares fall 1.40% premarket after beating Q2 revenue estimates and raising FY guidance. - AInvest
Elanco Animal Health Reports Strong Q2 2025 Results - TipRanks
What institutional flow reveals about Elanco Animal Health IncorporatedStrong Buy Signal Summary with Entry Zone - Newser
Elanco Animal Health Inc (ELAN) Q2 2025 Earnings Call Highlights: Strong Pet Health Growth and ... By GuruFocus - Investing.com Canada
Elanco Animal Health 2025 Q2 Earnings Strong Performance as Net Income Surges 122% - AInvest
Elanco Raises 2025 Innovation Revenue Outlook to $720M-$800M, Signals Margin Expansion Through New Launches. - AInvest
10 Hot Stocks Making Winning Look Easy - Insider Monkey
Elanco (ELAN) Q2 Revenue Jumps 5% - AOL.com
Elanco's Q2 2025 Earnings Call: Unraveling Key Contradictions in FX Impact, Innovation Growth, and Margin Dynamics - AInvest
Elanco Animal Health Q2 2025: Innovation-Driven Growth and Accelerated Deleveraging Justify a Buy Rating - AInvest
Elanco Animal Health shares fall 1.55% after-hours despite beating Q2 revenue estimates and raising FY guidance. - AInvest
Elanco's Q2 Revenue Exceeds Expectations, Raises Full-Year Guidance - AInvest
Elanco bolsters parvovirus treatment with new approval - Inside INdiana Business
Elanco (NYSE:ELAN) Delivers Impressive Q2, Stock Jumps 15.4% - Yahoo Finance
Elanco Animal Health Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Earnings call transcript: Elanco Animal Health beats Q2 2025 expectations By Investing.com - Investing.com Canada
Elanco Animal Health Incorporated (ELAN) Q2 Earnings and Revenues Beat Estimates - MSN
Why Is Elanco Animal Health Stock Soaring Thursday?Elanco Animal Health (NYSE:ELAN) - Benzinga
Elanco Animal Health stock hits 52-week high at $15.79 By Investing.com - Investing.com Canada
Elanco Animal Health (ELAN) Reports Q2 Earnings: What Key Metrics Have to Say - Yahoo Finance
Elanco Animal Health Inc SEC 10-Q Report - TradingView
Elanco stock spikes after Q2 beat, guidance raise (ELAN:NYSE) - Seeking Alpha
Elanco Animal Health’s Stock Faces Unusual Movement - TipRanks
Elanco (ELAN) Q2 Revenue Jumps 5% - The Motley Fool
Elanco Animal Health earnings beat by $0.06, revenue topped estimates - Investing.com Canada
Elanco Q2 2025 slides: 8% organic growth drives raised guidance despite headwinds - Investing.com Canada
Elanco Animal Health beats Q2 revenue estimates, raises FY guidance - MarketScreener
Elanco Animal Health Reports Second Quarter 2025 Results - TradingView
Elanco raises full-year guidance on strength of newest products - Indianapolis Business Journal
Curious about Elanco Animal Health (ELAN) Q2 Performance? Explore Wall Street Estimates for Key Metrics - Yahoo Finance
What To Expect From Elanco’s (ELAN) Q2 Earnings - Yahoo Finance
P/E Ratio Insights for Elanco Animal Health - 富途牛牛
What catalysts could drive Elanco Animal Health Incorporated stock higher in 2025Build wealth steadily with proven investment techniques - Jammu Links News
How does Elanco Animal Health Incorporated generate profit in a changing economyBuild a diversified portfolio for stability - Jammu Links News
How many analysts rate Elanco Animal Health Incorporated as a “Buy”Identify breakout stocks before they peak - Jammu Links News
How volatile is Elanco Animal Health Incorporated stock compared to the marketAchieve breakthrough financial results - Jammu Links News
Will Elanco Animal Health Incorporated rebound enough to break evenSwing Trading Plan With Smart Signals in Review - metal.it
Elanco Animal Health Inc (ELAN) 財務データ
収益
当期純利益
現金流量
EPS
Elanco Animal Health Inc (ELAN) インサイダートレーディング
インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
---|---|---|---|---|---|---|---|
Kurzius Lawrence Erik | Director |
Mar 07 '25 |
Buy |
10.90 |
10,000 |
109,000 |
101,459 |
Kurzius Lawrence Erik | Director |
Mar 11 '25 |
Buy |
10.20 |
10,000 |
102,000 |
111,459 |
HOOVER R DAVID | Director |
Mar 05 '25 |
Buy |
10.90 |
25,000 |
272,558 |
210,000 |
Harrington Michael J | Director |
Aug 22 '24 |
Buy |
14.85 |
3,500 |
51,974 |
81,094 |
Simmons Jeffrey N | PRESIDENT, CEO AND DIRECTOR |
Aug 12 '24 |
Buy |
13.01 |
100,000 |
1,300,610 |
145,000 |
大文字化:
|
ボリューム (24 時間):